Bone-targeting endogenous secretory receptor for advanced glycation end products rescues rheumatoid arthritis.

Takahashi T, Katsuta S, Tamura Y, Nagase N, Suzuki K, Nomura M, Tomatsu S, Miyamoto K, Kobayashi S

Open source

DOI
10.2119/molmed.2012.00309
Published
2013 Jul 24
Container
Molecular medicine (Cambridge, Mass.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2119/molmed.2012.00309,
  title = {Bone-targeting endogenous secretory receptor for advanced glycation end products rescues rheumatoid arthritis.},
  author = {Takahashi T and Katsuta S and Tamura Y and Nagase N and Suzuki K and Nomura M and Tomatsu S and Miyamoto K and Kobayashi S},
  year = {2013},
  journal = {Molecular medicine (Cambridge, Mass.)},
  doi = {10.2119/molmed.2012.00309},
  url = {https://doi.org/10.2119/molmed.2012.00309}
}

RIS

TY  - JOUR
TI  - Bone-targeting endogenous secretory receptor for advanced glycation end products rescues rheumatoid arthritis.
AU  - Takahashi T
AU  - Katsuta S
AU  - Tamura Y
AU  - Nagase N
AU  - Suzuki K
AU  - Nomura M
AU  - Tomatsu S
AU  - Miyamoto K
AU  - Kobayashi S
PY  - 2013
JO  - Molecular medicine (Cambridge, Mass.)
DO  - 10.2119/molmed.2012.00309
UR  - https://doi.org/10.2119/molmed.2012.00309
ER  - 

APA

T, T., S, K., Y, T., N, N., K, S., M, N., S, T., K, M., & S, K. (2013). Bone-targeting endogenous secretory receptor for advanced glycation end products rescues rheumatoid arthritis.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.2119/molmed.2012.00309

Source records